BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15506465)

  • 1. [Endothelin and essential hypertension].
    Kataoka K; Kurihara Y; Kurihara H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():640-3. PubMed ID: 15506465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects for endothelin-related drugs].
    Goto K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():673-81. PubMed ID: 15506472
    [No Abstract]   [Full Text] [Related]  

  • 3. [Involvement of endothelin in the pathogenesis of hypertension and hypertensive target-organ damage].
    Kanno K; Hirata Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():164-8. PubMed ID: 15171363
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of endothelin-1 on vascular structure and function.
    Stewart DJ
    Am J Cardiol; 1998 Nov; 82(10A):14S-16S. PubMed ID: 9860349
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelin-1 in heart failure: does it play a role?
    Sam F; Colucci WS
    Cardiologia; 1998 Sep; 43(9):889-92. PubMed ID: 9859602
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endothelin].
    Maeda S; Miyauchi T; Goto K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
    [No Abstract]   [Full Text] [Related]  

  • 7. Bosentan in essential hypertension.
    Haynes WG; Ferro CJ; Webb DJ
    N Engl J Med; 1998 Jul; 339(5):346; author reply 347. PubMed ID: 9696644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Discovery of endothelin and its significance].
    Goto K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():575-83. PubMed ID: 15506451
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of endothelin-1 in myocardial failure.
    Sam F; Colucci WS
    Proc Assoc Am Physicians; 1999; 111(5):417-22. PubMed ID: 10519162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endothelin and heart failure].
    Miyauchi T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():648-54. PubMed ID: 15506467
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelin-1 and the pulmonary vascular response to altitude: a new therapeutic target?
    Rubin LJ
    Circulation; 2006 Sep; 114(13):1350-1. PubMed ID: 17000920
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversing congestive heart failure with endothelin receptor antagonists.
    Yazaki Y; Yamazaki T
    Circulation; 1997 Apr; 95(7):1752-4. PubMed ID: 9107157
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
    Brochu I; Labonté J; Bkaily G; D'Orléans-Juste P
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():380S-384S. PubMed ID: 12193127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
    Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
    N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptor antagonists: actions and rationale for their development.
    Warner TD; Battistini B; Doherty AM; Corder R
    Biochem Pharmacol; 1994 Aug; 48(4):625-35. PubMed ID: 8080434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endothelin receptors].
    Goto K
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):961-6. PubMed ID: 10771658
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion.
    Alberola Aguilar AM; Revert F; Moya A; Beltrán J; García J; San Martín E; Sancho S; Such L
    Gen Pharmacol; 2000 Sep; 35(3):143-7. PubMed ID: 11744236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin and its antagonists in hypertension: can we foresee the future?
    Moreau P; Rabelink TJ
    Curr Hypertens Rep; 1999; 1(1):69-78. PubMed ID: 10981045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetically altered rodent models in the endothelin-related genes].
    Emoto N; Yokoyama M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():311-5. PubMed ID: 16897870
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
    Kowala MC; Murugesan N; Tellew J; Carlson K; Monshizadegan H; Ryan C; Gu Z; Kane B; Fadnis L; Baska RA; Beyer S; Arthur S; Dickinson K; Zhang D; Perrone M; Ferrer P; Giancarli M; Baumann J; Bird E; Panchal B; Yang Y; Trippodo N; Barrish J; Macor JE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):275-84. PubMed ID: 14718594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.